Lou Gehrig’s

Home/Tag: Lou Gehrig’s

New ALS therapy in clinical trials

About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The invariably fatal disease kills the nerve cells that control walking, eating and breathing. Few people survive more than three years after diagnosis. Now, new research led by Washington University School of Medicine in St.